Curing Death by Curing Aging (Free subscription) | 08/05/2008
Protein protects liver against accumulation of excess bile; implications for treating liver diseases
Medical News Today (Free subscription) | 08/02/2008
Two new studies examine the use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C. The reports appear in the August issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The articles are available online at Wiley Interscience (http://www.interscience.wiley.com/).
Physorg (Free subscription) | 07/31/2008
Two new studies examine the use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C. The reports appear in the August issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).
Medical News Today (Free subscription) | 07/24/2008
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug. The findings, published in the July 23rd, 2008 issue of the New England Journal of Medicine, is a significant advance in the management of liver cancer, which is the third...
Red Orbit (Free subscription) | 07/10/2008
Pro-Pharmaceuticals, Inc. (AMEX: PRW), a company developing proprietary carbohydrate-based therapeutic compounds to treat serious diseases such as cancer and fibrosis, has named Scott L. Friedman, M.D., to its Scientific Advisory Board. Dr.
Medical News Today (Free subscription) | 07/10/2008
A new study in the journal Psychophysiology reveals that men, but not women, vaccinated in the morning produced a better peak antibody response to both hepatitis A and the influenza strain. Led by Anna Catriona Phillips of the University of Birmingham, researchers assessed the response to a hepatitis A vaccine in young healthy adults and also examined responses to the annual influenza vaccination in...
Eurekalert (Free subscription) | 07/09/2008
A key enzyme may explain how hepatitis C infection leads to serious liver diseases, reports the University of Pittsburgh Graduate School of Public Health. The study, to be published in the July 9 online issue of Hepatology, shows that fatty acid synthase is highly elevated in human liver cells exposed to the hepatitis C virus, suggesting that testing enzyme levels could help predict more serious, long-lasting...
Science Daily (Free subscription) | 07/09/2008
A key enzyme may explain how hepatitis C infection leads to serious liver diseases. A new shows that fatty acid synthase is highly elevated in human liver cells exposed to the hepatitis C virus, suggesting that testing enzyme levels could help predict more serious, long-lasting health consequences from hepatitis C.
http://maps.grida.no/go/feedrandom (Free subscription) | 06/29/2008
Communities face appalling health problems. In Karakalpakstan, Uzbekistan, drinking water is saline and polluted, with a high content of metals that causes a range of diseases. Over the past 15 years there has been a thirty-fold increase in chronic bronchitis and in kidney and liver diseases, especially cancer and arthritic diseases have increased sixty-fold. The infant mortality rate is one of the...
Hindu (Free subscription) | 06/01/2008
HYDERABAD: Care hospitals has set-up a multi-discipline liver clinic to provide holistic services for various kinds of liver diseases, a release said. Patients with chronic liver ailments would be given comprehensive evaluation and treatment ...
Medical News Today (Free subscription) | 05/23/2008
With the launch of the Hepatitis C Action Plan for Scotland Phase II, the Scottish Government has promised over £43 million to help tackle the spread of this virus. The plan will help to significantly improve testing, treatment, care and support services for Hepatitis C across Scotland. In addition, in order to increase prevention, national education and awareness initiatives will also be increased....
Medical News Today (Free subscription) | 05/22/2008
In rats with diethyl nitrosamine induced cirrhosis, TSP-1 expression has been found to correlate with the progression of fibrosis. Furthermore, TSP-1 expression was higher in rat livers with high vascular density - in other words, angiogenesis. This study, performed by a team led by Dr. Gulsum Ozlem Elpek, is described in a research article published in the World Journal of Gastroenterology.
Medical News Today (Free subscription) | 05/22/2008
Hepatitis C is a health care problem all over the world, with 130 million patients infected the world over. The treatment is expensive and has variable results according to the genotype of the infecting virus. The first land mark in treatment is the virus clearance at the end of the treatment called End Treatment Response (ETR), but many of the patients achieving the ETR have a relapse within the next...
Medical News Today (Free subscription) | 05/22/2008
Alcoholic threshold effect rather than a dose-response effect on mortality from alcohol-related liver injury. Alcohol intake, rather than the type of alcoholic beverage, was more significant to liver injury.This study, performed by a team led by by Professor You-Ming Li from Zhejiang University, is described in a research article published in the World Journal of Gastroenterology.
Medical News Today (Free subscription) | 05/21/2008
Variceal hemorrhaging is associated with a high mortality rate. The early detection of esophageal varices is critical for the effective prevention of variceal hemorrhage.In daily medical practice, it is common to encounter patients with liver damage from chronic alcohol consumption. When the alcoholic patient is examined, it is often evident that alcoholic liver damage is progressing.
